When people search for semaglutide or tirzepatide online, they quickly run into two very different categories: brand-name medications such as Wegovy, Ozempic, Zepbound and Mounjaro, and compounded versions prepared by pharmacies. Both are often described with the same ingredient names, which can make them sound interchangeable. They are not, and understanding the difference helps you make an informed decision with your provider.
What brand-name GLP-1s are
Brand-name GLP-1 medications are manufactured by pharmaceutical companies and reviewed by the FDA for safety, effectiveness and manufacturing quality. Their labels spell out approved uses, dosing and warnings.
- Wegovy (semaglutide) is FDA-approved for chronic weight management and to lower the risk of major cardiovascular events in certain adults with heart disease.
- Zepbound (tirzepatide) is FDA-approved for chronic weight management and for moderate to severe obstructive sleep apnea in adults with obesity.
- Ozempic (semaglutide) is FDA-approved for type 2 diabetes. It is not approved for weight loss, though it is sometimes prescribed off-label.
- Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes, not for weight loss.
These products come in prefilled pens or other standardized delivery systems with fixed doses, which reduces the chance of measuring errors.
What compounded GLP-1s are
Compounding is the practice of a licensed pharmacy preparing a medication for an individual patient based on a prescription. It has a long, legitimate history, for example making a liquid version of a pill for someone who cannot swallow tablets, or leaving out an ingredient a patient is allergic to.
Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they reach patients. Compounding pharmacies are overseen by state boards of pharmacy, and larger outsourcing facilities register with the FDA and follow stricter manufacturing standards, but neither pathway is the same as FDA approval of a finished product.
Compounded versions are typically supplied as multi-dose vials that you draw up with a syringe, and some pharmacies prepare sublingual tablets or drops. Some add ingredients such as vitamin B12 or glycine. These additions have not been shown to improve results in large trials.
Key differences that matter to patients
Evidence
The large clinical trials, such as STEP for semaglutide and SURMOUNT for tirzepatide, studied the brand-name products. Average results from those studies, roughly 15 percent body weight loss with semaglutide 2.4 mg and up to about 21 percent with the highest tirzepatide dose, do not automatically transfer to compounded versions, which have not been tested the same way.
Dosing accuracy
Pens deliver a set dose with a click. Vials require you to measure in units on a syringe, and compounded concentrations can differ between pharmacies. The FDA has received reports of dosing errors with compounded GLP-1s, including patients drawing up several times the intended amount. Clear instructions and careful teaching from your care team are essential.
Ingredient form
Some compounded products have used salt forms of semaglutide, such as semaglutide sodium, which differ from the base form used in approved medications. The FDA has warned about these. A reputable pharmacy should be able to tell you exactly what is in your vial.
Availability and regulation
Compounding of copies of commercially available drugs is restricted under federal law, with exceptions during shortages or when a prescriber determines a patient needs a meaningful clinical difference. Rules and enforcement have shifted over time, so availability can change.
Questions to ask before you start
Whether you are leaning toward brand-name or compounded medication, these questions help you choose with confidence:
Which pharmacy prepares or dispenses the medication, and is it licensed in your state? Is it a 503A pharmacy or a 503B outsourcing facility? What exactly is the active ingredient, and is it the base form? What concentration is in the vial, and how many units equal your dose? Who do you contact if you have side effects or questions about measuring? How often will your provider check in and adjust your plan?
A responsible clinic is comfortable answering every one of these plainly.
How a provider helps you decide
A licensed provider weighs your medical history, insurance coverage, comfort with injections, and how important FDA approval is to you. For many patients, a brand-name option is the clear first choice. For others, a compounded medication may be considered after a frank discussion of the tradeoffs. Either way, the medication should be prescribed only if it is clinically appropriate, and your care should include regular follow-up, side effect support and nutrition guidance.
Talk to a provider
If you want an honest conversation about brand-name versus compounded GLP-1 options, Aurora Weight Loss can help. Get started online with a short questionnaire. A licensed provider reviews your answers, explains which options fit your situation, and prescribes only when appropriate. If prescribed, medication ships from a licensed US pharmacy, and pricing is shown after your provider review because it depends on the treatment plan.
Medical disclaimer: This article is for general education and is not medical advice, so please discuss your options with a licensed provider.
Thinking about treatment in Aurora, CO?
Aurora Weight Loss providers review every case online and ship medication across the Aurora area when it is appropriate.